The results of the recent investigation have shown that galectin-3 levels were significantly elevated in type 2 diabetes mellitus patients with macroalbuminuria, and higher levels of galectin-3 were found in patients with advanced kidney function (stage 4 and 5 CKD) [94]. The gene discussed is LGALS3; the disease is chronic kidney disease.